GSK, the FTSE 100 drugmaker, said its immunotherapy Jemperli (dostarlimab) produced a complete response in 76% of patients ...
It seems we cannot go a week without hearing about some new health or beauty craze, usually on social media sites that cater ...
AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen ...
Responses were deep and durable, with 65% ongoing at clinical cutoff; Results support continued evaluation of the ...
Julie-Ann spent more than 10 years searching for answers as her health spiralled and doctors struggled to explain why. Then a ...
Many people are likely considering light therapy or laser treatment to improve spots and hyperpigmentation, aren't they?I am ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results